Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $21
Piper Sandler analyst Christopher Raymond maintains $ALX Oncology(ALXO.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 51.3%
ALX Oncology(ALXO.US) Officer Sells US$10,025.22 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pinto Shelly sold 1,823 shares of common stock on Jul 5, 2024 at an average price of $5.4993 for a total value of $10,025.22.Source: Announcement What is statement of
ALX Oncology(ALXO.US) Officer Sells US$19,044.93 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Randolph Sophia sold 3,273 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $19,044.93.Source: Announcement What is statement o
ALX Oncology(ALXO.US) Officer Sells US$7,989.21 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pinto Shelly sold 1,373 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $7,989.21.Source: Announcement What is statement of ch
ALX Oncology(ALXO.US) Officer Sells US$62,598.65 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pons Jaume sold 10,758 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $62,598.65.Source: Announcement What is statement of ch
Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
(SEC Amendment) ALX Oncology(ALXO.US) Officer Buys US$102.34K in Common Stock
$ALX Oncology(ALXO.US)$ Officer GARCIA PETER S purchased 12,000 shares of common stock on Jun 13, 2024 at an average price of $8.5282 for a total value of $102.34K.Source: Announcement What is stateme
Peter Garcia Bought 31% More Shares In ALX Oncology Holdings
Potential ALX Oncology Holdings Inc. (NASDAQ:ALXO) shareholders may wish to note that the Chief Financial Officer, Peter Garcia, recently bought US$102k worth of stock, paying US$8.53 for each share.
Insider Buying: CFO Peter Garcia Acquires Shares of ALX Oncology Holdings Inc (ALXO)
ALX Oncology(ALXO.US) Officer Buys US$102.34K in Common Stock
$ALX Oncology(ALXO.US)$ Officer GARCIA PETER S purchased 12,000 shares of common stock on Jun 13, 2024 at an average price of $8.5282 for a total value of $102.34K.Source: Announcement What is stateme
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright analyst Swayampakula Ramakanth maintains $ALX Oncology(ALXO.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of
ALX Oncology(ALXO.US) Officer Sells US$168.65K in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pons Jaume sold 20,000 shares of common stock on Jun 4, 2024 at an average price of $8.4326 for a total value of $168.65K.Source: Announcement What is statement of chan
ALX Oncology Down Over 15%, on Pace for Largest Percent Decrease Since December 2021 -- Data Talk
ALX Oncology Holdings, Inc. (ALXO) is currently at $8.99, down $1.64 or 15.43% --Would be lowest close since Dec. 6, 2023, when it closed at $8.43 --On pace for largest percent decrease since Dec. 1
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Express News | ALX Oncology Presents First Evorpacept Combination Data With an Antibody-Drug Conjugate From Phase 1 Aspen-07 Clinical Trial in Patients With Advanced Bladder Cancer
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug